Paulo Andre Zagman Sells 136,250 Shares of Ambev (NYSE:ABEV) Stock

Ambev S.A. (NYSE:ABEV) insider Paulo Andre Zagman sold 136,250 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $3.41, for a total transaction of $464,612.50. Following the completion of the sale, the insider directly owned 230,535 shares in the company, valued at approximately $786,124.35. This trade represents a 37.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Ambev Stock Performance

Shares of NYSE ABEV traded up $0.12 during midday trading on Thursday, hitting $3.23. The company’s stock had a trading volume of 31,909,123 shares, compared to its average volume of 26,187,105. The stock has a fifty day moving average price of $3.12 and a 200 day moving average price of $2.87. Ambev S.A. has a one year low of $2.10 and a one year high of $3.45. The company has a current ratio of 1.03, a quick ratio of 0.78 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $50.83 billion, a price-to-earnings ratio of 16.97, a P/E/G ratio of 1.79 and a beta of 0.64.

Ambev (NYSE:ABEV) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. Ambev had a net margin of 17.69% and a return on equity of 16.63%. The company had revenue of $4.32 billion for the quarter, compared to analyst estimates of $4.38 billion. On average, research analysts forecast that Ambev S.A. will post 0.21 EPS for the current fiscal year.

Ambev Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, June 24th will be given a $0.0092 dividend. The ex-dividend date of this dividend is Wednesday, June 24th. This represents a $0.04 annualized dividend and a dividend yield of 1.1%. Ambev’s payout ratio is 10.53%.

Institutional Trading of Ambev

A number of hedge funds and other institutional investors have recently bought and sold shares of ABEV. Kiltearn Partners LLP grew its stake in Ambev by 5.6% in the 3rd quarter. Kiltearn Partners LLP now owns 11,045,700 shares of the company’s stock worth $24,632,000 after buying an additional 590,000 shares in the last quarter. B. Metzler seel. Sohn & Co. AG grew its stake in Ambev by 187.7% in the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 2,128,785 shares of the company’s stock worth $5,263,000 after buying an additional 1,388,881 shares in the last quarter. MH & Associates Securities Management Corp ADV purchased a new position in Ambev in the 4th quarter worth approximately $1,727,000. Exchange Traded Concepts LLC grew its stake in Ambev by 41.5% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,588,912 shares of the company’s stock worth $13,805,000 after buying an additional 1,638,227 shares in the last quarter. Finally, Advisors Preferred LLC purchased a new position in Ambev in the 3rd quarter worth approximately $1,690,000. Institutional investors own 8.13% of the company’s stock.

Analyst Upgrades and Downgrades

ABEV has been the topic of several research reports. Weiss Ratings lowered shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, May 6th. Barclays upped their target price on shares of Ambev from $3.00 to $3.50 and gave the stock an “equal weight” rating in a report on Wednesday, May 6th. Wall Street Zen raised shares of Ambev from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, UBS Group upped their target price on shares of Ambev from $2.65 to $2.90 and gave the stock a “sell” rating in a report on Thursday, May 14th. Five analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $3.09.

Ambev Company Profile

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.